
CTX-Platforms
Company description
See translation
CTX-Platforms is launching a cancer-targeting peptide platform based on a patent-pending synthetic molecule derived from scorpion venom, which can easily penetrate the bloodbrain barrier as well as solid tumors outside the central nervous system. The pep...
HS code: {{pas.hsCode | limitTo: 23}}
Commercial information
Affiliations:
People in this company (1)
Contact this company through Start-Up Nation Central
To get in touch with the ConnectAmericas support team, please send an e-mail with your request to soporte@connectamericas.com and we will get back to you briefly.
Follow Us